Secondary and tertiary prevention of type 2 diabetes: a study protocol for a randomized, controlled trial in community pharmacies in bavaria, germany

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: PRAX, Katja (Friedrich-Alexander University Erlangen-Nuremberg, Molecular & Clinical Pharmacy, Erlangen, Germany)
  • Co-author(s): Katja Prax: Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
    Helmut Schlager: Scientific Institute for Prevention in Health Care (WIPIG), Munich, Germany
    Kristina Friedland: Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
  • Abstract:

    Background

    Type 2 diabetes patients have a high risk for micro- and macrovascular complications. Hereby, a poor glycemic control leads to progression of disease, hospitalization and reduced life expectancy. In Germany there is lack of evidence regarding a community pharmacist intervention to improve glycemic control of diabetics.

    Purpose

    The

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login